Skip to main content
. 2024 Jul 17;12(7):784. doi: 10.3390/vaccines12070784

Figure 1.

Figure 1

Anti-RBD IgG (A) and Omicron BA.5-neutralizing antibody (B) levels measured in serum of patients undergoing PrEP. Dot lines represent the cut-offs of the assays. Kruskal–Wallis and Dunn’s tests were performed for statistical comparisons. Red lines in 1B represent geometric mean values.